Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001591986-25-000002
Filing Date
2025-02-14
Accepted
2025-02-14 11:59:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12401
2 aqu_ex1.pdf EX-1 48071
  Complete submission text file 0001591986-25-000002.txt   80654
Mailing Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701
Business Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 919-314-5512
PRECISION BIOSCIENCES INC (Subject) CIK: 0001357874 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90975 | Film No.: 25625350
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address ONE LETTERMAN DRIVE SUITE D4900, BUILDING D SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE SUITE D4900, BUILDING D SAN FRANCISCO CA 94129 415-635-0140
Aquilo Capital Management, LLC (Filed by) CIK: 0001591986 (see all company filings)

EIN.: 272448001 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A